BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232 [PMID: 34876784 DOI: 10.3748/wjg.v27.i42.7210]
URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7210.htm
Number Citing Articles
1
Wannarat Chanket, Methinee Pipatthana, Apiwat Sangphukieo, Phurt Harnvoravongchai, Surang Chankhamhaengdecha, Tavan Janvilisri, Matthew Phanchana. The complete catalog of antimicrobial resistance secondary active transporters in Clostridioides difficile: evolution and drug resistance perspectiveComputational and Structural Biotechnology Journal 2024; 23: 2358 doi: 10.1016/j.csbj.2024.05.027
2
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, Francesco Marotta. Probiotics as Live Biotherapeutics for Veterinary and Human Health, Volume 22024; : 771 doi: 10.1007/978-3-031-65459-6_36
3
Matthew Phanchana, Methinee Pipatthana, Tanaporn Phetruen, Pattanai Konpetch, Pattaneeya Prangthip, Phurt Harnvoravongchai, Chanakarn Sripong, Sombat Singhakaew, Sarawut Wongphayak, Surang Chankhamhaengdecha, Tavan Janvilisri. Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficileBiomedicine & Pharmacotherapy 2024; 180: 117469 doi: 10.1016/j.biopha.2024.117469
4
Marcos Hernando-Gozalo, Carlos Rescalvo-Casas, Laura Seijas-Pereda, Juan Cuadros-González, Ramón Pérez-Tanoira. Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort studyHeliyon 2024; 10(10): e30742 doi: 10.1016/j.heliyon.2024.e30742
5
Ádám Kerek, Ábel Szabó, Péter Ferenc Dobra, Krisztina Bárdos, László Ózsvári, Péter Fehérvári, Zsófia Bata, Viviána Molnár-Nagy, Ákos Jerzsele. Determining the In Vivo Efficacy of Plant-Based and Probiotic-Based Antibiotic Alternatives against Mixed Infection with Salmonella enterica and Escherichia coli in Domestic ChickensVeterinary Sciences 2023; 10(12): 706 doi: 10.3390/vetsci10120706
6
Mohamed Halawa, Maxwell Akantibila, Briana E. Reid, Valerie J. Carabetta. Therapeutic proteins have the potential to become new weapons in the fight against antibiotic resistanceFrontiers in Bacteriology 2023; 2 doi: 10.3389/fbrio.2023.1304444
7
Wichuda Phothichaisri, Tanaporn Phetruen, Surang Chankhamhaengdecha, Tavan Janvilisri, Puey Ounjai, Robert P. Fagan, Sittinan Chanarat. BacteriophagesMethods in Molecular Biology 2024; 2738: 245 doi: 10.1007/978-1-0716-3549-0_16
8
Pooja Chaukimath, Gad Frankel, Sandhya S. Visweswariah. The metabolic impact of bacterial infection in the gutThe FEBS Journal 2023; 290(16): 3928 doi: 10.1111/febs.16562
9
Mahdi Asghari Ozma, Manouchehr Fadaee, Hamideh Mahmoodzadeh Hosseini, Mohammad Hossein Ataee, Seyed Ali Mirhosseini. A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial InfectionsProbiotics and Antimicrobial Proteins 2024;  doi: 10.1007/s12602-024-10406-0
10
Dorota Wultańska, Michał Piotrowski, Hanna Pituch. Antimicrobial Effects of Some Natural Products on Adhesion and Biofilm Inhibition of Clostridioides difficilePharmaceutics 2024; 16(4): 478 doi: 10.3390/pharmaceutics16040478